The latest death marks the third treatment-related fatality this year. Two teenage boys have died after receiving Sarepta's Elevidys, a gene therapy approved to treat a rare muscular dystrophy. Sign ...

Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, ...